Life sciences and healthcare forum BioAsia whose 18th edition is to be held virtually, for the first time, on February 22 and 23 will focus on COVID-19, global health, pharma and medtech.
The conference will provide a unique opportunity to pharma and biotech companies, CROs, CMOs, CDMOs, biotech startups, academic institutions, scientists and researchers, policy makers and regulatory experts from world over to discuss coronavirus and other topics related to the life sciences industry, a statement from the organisers on Tuesday said.
The conference will offer insights on India’s current and future potential in immunising the world and key actions taken to become the future global innovative vaccine provider. Experts will discuss innovation at the intersection of healthcare, technology, and finance, promoting affordable and accessible innovation in the healthcare sector. Discussions will also focus on learnings from COVID to develop robust healthcare systems and respond better to the next pandemic, the release said.
A session will be devoted to the prospects of medical technologies becoming the next big opportunity for India. The CEO conclave will deliberate on supply chain resilience, innovation and research and access to innovative medicines. “We are expecting BioAsia 2021 to be bigger than previous editions. There is considerable interest from corporates, academia and startups to participate,” said Shakthi Nagappan, CEO of BioAsia and director of Telangana Life Sciences.
You have reached your limit for free articles this month.
Subscription Benefits Include
Today's Paper
Find mobile-friendly version of articles from the day's newspaper in one easy-to-read list.
Unlimited Access
Enjoy reading as many articles as you wish without any limitations.
Personalised recommendations
A select list of articles that match your interests and tastes.
Faster pages
Move smoothly between articles as our pages load instantly.
Dashboard
A one-stop-shop for seeing the latest updates, and managing your preferences.
Briefing
We brief you on the latest and most important developments, three times a day.
Support Quality Journalism.
*Our Digital Subscription plans do not currently include the e-paper, crossword and print.
A letter from the Editor
Dear subscriber,
Thank you!
Your support for our journalism is invaluable. It’s a support for truth and fairness in journalism. It has helped us keep apace with events and happenings.
The Hindu has always stood for journalism that is in the public interest. At this difficult time, it becomes even more important that we have access to information that has a bearing on our health and well-being, our lives, and livelihoods. As a subscriber, you are not only a beneficiary of our work but also its enabler.
We also reiterate here the promise that our team of reporters, copy editors, fact-checkers, designers, and photographers will deliver quality journalism that stays away from vested interest and political propaganda.
Suresh Nambath
